T cells potentially encounter numerous endogenous peptides during selection in the thymus and in the periphery. We examined the impact of an endogenous peptide on in vivo T cell development, using a TCR transgenic mouse model based on a hemoglobin-specific T cell clone. In these mice, the transgenic ~ chains paired with endogenous ot chains. This led to a serendipitous primary reactivity to Set69 peptide, an altered peptide ligand of the Hb a (64-76) epitope of the parent clone. Two Ser69-reactive T cell populations were identified. A smaller population of the Ser69-reactive T cells responded both to . A majority reacted only to Set69, and not to Hba(64-76); in fact, Hba(64-76) was a specific TCR antagonist for these Ser69-onlyreactive T cells. Thus, in this unique experimental system, Ser69 became an agonist, and Hb a (64-76) was an antagonist. Endogenous presentation of the antagonist ligand in the thymus selectively eliminated the high-avidity cells, while sparing low-avidity cells in the Ser69-reactive T cell repertoire. These results highlight how specificity guides developing T cells through a network of ligands and indicate that the endogenous peptide pool has a profound effect on T cell development and repertoire.
T he antigen specificity of the TCR is central to the triggering of T cell activation, clonal expansion, and effector functions. The TCR recognizes its antigen in the form of a peptide bound to an MHC molecule. Studies using variants of antigenic peptides have shown that the TCR responds selectively to subtle changes in the ligand, underscoring its ability to behave as more than an all-or-none switch (1, 2) . We have approached these issues of T cell recognition by characterizing the T cell response to the B chain of murine hemoglobin, a protein with two allelic forms, Hbb s and Hbb d. The single antigenic determinant Hb ~a~n~ (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) [hereafter referred to as Hbd(64-76)] binds to I-E k and is expressed as a self-antigen in CBA/J (Hbb a) mice, while it is recognized as foreign in CE/J (Hbb s) mice. Using variants of Hba(64-76), termed altered peptide ligands (APL), we have demonstrated the induction of selective functions in T cell clones and hybridomas, including lymphokine production or cytolysis without proliferation (3, 4) , anergy induction (5, 6) , and TCR antagonism (4) . We report here a transgenic mouse expressing the/3 chain of the TCR from a Hbd(64-76)/I-Ek-specific T cell clone, which has a fortuitous primary reactivity to an APL of Hbd(64-76). We introduced the Hbd(64-76)-determinant into the pool of endogenous peptide ligands by crossing these mice with Hbbd-expressing mouse strains and examined the effect of endogenous APL on thymic selection.
Materials and Methods

TCR-transgenic Mice.
The parent clone of the G2-Tg mice was the Hbd(64-76)/I-Ek-specific Th2 clone, 2.102, derived from a CE/J (Hbb S) mouse (7) . Minigenes of the 2.102 TCR-c~ and -/8 chains were constructed by insertion of V-Jot and V-D-J/8 exon cassettes into cr and/3 transgene shuttle vectors, respectively (kindly provided by M. Davis (Stanford University, Palo Alto, CA) (8), then coinjected into (B6 x SJL)F2 zygotes at DNX Corp. (Princeton, NJ). Founder transgenic mice (G2-Tg) were obtained and backcrossed twice to CE/J mice to introduce the I-E k restriction element and maintain homozygosity of the Hbb s allele. PCR amplification of the a transgene from tail digests identified transgenic progeny (9) . Mice used in the experiments described in this report were homozygous H-2 k/k by FACS or a PCR-based screen.
Initial examination of thymocytes and splenocytes revealed no relative increase in CD4 § T cells in the transgenic progeny and a weak response to Hbd(64-76). The TCR-/8 chain transgene, a V/81-D/81-J/82.4 rearrangement, was functional and resulted in suppression of endogenous/8 chain rearrangements in >95% ofT cells, as determined by flow cytometry. In regard to the ~ chain (Vot2-Joe41) transgene, no increase in Vc~2 + T cells in G2-Tg mice was detected by an anti-Vot2 antibody (10) . Another c~ transcript (Vot4-Jc~48) subsequently was isolated from the parent 2.102 clone that bore strong homology to oe chains isolated from other Hbb aspecific T cells, suggesting that the Vc~2 chain used to make the transgene was not involved in Hb recognition.
cell proliferation assays were performed as described (7, 11) . TCR antagonist assays of T cell hybridomas were performed as described (4) . The antagonist assay for primary T cells was done similarly except that mitomycin C-treated, DCEK.Hi7 I-Ek-bearing L cells (5) prepulsed with 20 #M Ser69 were the stimulatory APC, and nylon wool-purified T cells (2 x 105) from Hbb a/s TCR-transgenic mice were used. Reactions were heated to 94~ for 3 min, followed by four cycles of 97~ for 60 s, 52~ for 30 s, 72~ for 60 s, and 30 cycles of 94~ for 45 s, 52~ for 30 s, and 72~ for 60 s. PCR products (7 gl) were electrophoresed on a 3% agarose gel (NuSieve; FMC Corp., Rockland, ME) and visualized with ethidium bromide. Each Va PCR reaction yielding a band of the expected size was purified by filtration through a microconcentrator (Amicon, Beverly, MA), and then directly sequenced with a nested Ca sequencing primer (generously provided by K. Murphy, Washington University, St. Louis, MO) using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems, Foster City, CA) and a sequencer (model 373A; Applied Biosystems). TCR-a chain rearrangements were determined to be in frame or out of frame by analysis of the V-Ja junctional region sequences. All TCR-a V-J junctions differed at the nucleotide level. Va and Ja gene segments were assigned according to previous nomenclature (16, 17) . The Va2 transgene was transcribed in all of the hybridomas. Expression of the V/31 transgene, which had cointegrated with the a transgene, was verified for all hybridomas by activation by staphylococcal enterotoxin A (Toxin Technology, Sarasota, FL) and/or RNA PCR of the mature transcript of the/3 transgene.
Results and Discussion
To explore the effect of APL on unmanipulated primary T ceils, we generated a TCR-transgenic mouse based on the Hba(64-76)/I-Ek-specific Th2 clone 2.102 (7). Upon characterization, these G2-Tg mice were phenotypically TCR-/3 chain only-transgenic mice, because the TCR-a chain was not the one used by the 2.102 T cells for Hba(64-76) recognition. Thus, the T cells in the G2-Tg mice expressed a transgenic/3 chain paired with endogenous o~ chains. Further characterization of the G2-Tg mice revealed that the transgenic chain alone, in combination with endogenous a chains, was sufficient to confer antigen reactivity on unprimed T cells. Transgenic spleen cells responded weakly but specifically to either Hbb a protein or Hba(64-76) peptide (Fig. 1) . A variety of APL of Hba(64-76) were also assayed, given the possibility that TCR formed by the transgenic/3 chain and endogenous o~ chains would recognize the variants better than Hbd(64-76) itself. Interestingly, G2-Tg spleen cells proliferated strongly to Set69 (Fig. 1) . The vigorous proliferative response to Set69 indicated that the B chain alone had shaped To characterize the molecular basis for the Ser69 response, we generated a panel of Ser69-reactive T cell hybridomas from unprimed G2-Tg T cells stimulated in vitro with Ser69 and examined both specificity and TCR-c~ chain usage. These hybridomas separated into two major groups based on their specificity for Ser69 and Hba(64-76). One group (6/10) could be activated by Set69 only, not Hba(64-76), and predominantly expressed Vc~6-Jo~48 TCR-c~ rearrangements (Fig.  2 A) . The other group (4/10) consisted of T cells that were activated by both Ser69 and Hba(64-76), and half of these expressed Vc~4-Jo~33 TCR-c~ rearrangements (Fig. 2 B) .
Although the larger group of Ser69-reactive hybridomas was not activated by Hba(64-76), it was still possible that these T cells engaged Hba(64-76), but in a nonefficacious manner. Nonstimulatory peptides may act as specific antagonists of the response to the immunogenic ligand (4, 19) . Thus, Hba(64-76) was examined as a TCR antagonist of a representative Ser69-reactive hybridoma. For BT, a Vo16-Jo~48-bearing hybridoma, Hbd(64-76) was not an agonist ( Fig. 2 A) , but did antagonize Ser69-mediated activation in a specific and dose-dependent manner (Fig. 2 C) , while a control peptide did not. This finding demonstrated that although the BT TCR was activated only by Set69, it still could specifically interact with the Hbd(64-76) peptide. Thus, in the G2-Tg mouse, the roles of these two peptides had been reversed from the parent 2.102 clone (4), with Ser69 now being an The important role of peptide-specific interactions in T cell development was demonstrated in recent reports (20) (21) (22) . Peptides that could positively select in vitro in a TCR~x/B-transgenic system were TCR antagonists of the parent T cell clone (20) . Peptides that could negatively select would stimulate the parent clone (20, 21) . Extrapolating from these findings, we contend that each thymocyte must face a continuum of different potential ligands, and the effects these various ligands have on developing T cells need to be clarified. To study the effect of an endogenous antagonist on T cell development, we crossed the Ser69-reactive G2-Tg mice with CBA/J mice, which express the Hbb a allele. We had shown previously that in Hbb a mice, endogenous Hbba/I-E k complexes are constitutively expressed on thymic cortical epithelial cells and medullary APC populations (23) , establishing that these complexes would be available to interact with developing CD4 § T cells.
The presence of the Hbb a ligand altered the repertoire. In Hbb a/~ mice, vigorous T cell responses to Ser69 were observed, as had been found in Hbb s/s background mice. In marked contrast, however, cells from Hbb d/s mice failed to respond to Hbd(64-76) (Fig. 3 A) . These results suggested that the endogenous Hbb a ligand deleted at least all Hba(64-76)-reactive cells in the thymus, whereas Set69 onlyreactive cells were allowed to develop. To gauge whether the endogenous Hbb a ligand depleted the transgenic T cell repertoire of any and all cells that interacted with it, Hba(64-76) was assayed as a TCR antagonist peptide. As shown in Fig.  3 B, the primary Ser69 response by Hbb a/~ G2-Tg cells was strongly and specifically inhibited by Hba(64-76) peptide, indicating that the Ser69-reactive T cells were capable of recognizing the ligand as an antagonist, and that a single peptide ligand can inhibit an oligoclonal T cell response. Furthermore, our results clearly show that TCR antagonism of unprimed peripheral T cells can occur.
Comparison of the Set69 dose response of transgenic T cells from Hbb a/~ with that of Hbb s/s mice revealed that a higher dose of Set69 was required to elicit a proliferative response from Hbb a/~ cells (Fig. 3 C) . This shift in dose responses were remarkably consistent, in that the data shown in Fig. 3 C were obtained from four individual mice for each group, each assayed on different days. Thus, the observed differences represented a significant shift in the primary response of bulk T cells to Ser69. The elimination of Ser69/Hbd(64 -76) dual-reactive cells only accounts for a minor proportion of this decreased response of the Hbb d/~ G2-Tg cells, because in Hbb r mice these cells are a minority of Set69 responders (Fig. 2) , and the weak Hba(64-76) response (Fig. 1) suggests a similarly limited contribution by dual-reactive cells to the overall Set69 response.
The large shift in the Ser69 response in Hbb a/~ G2-Tg mice could be due in part to the endogenous Hbb a in the thymus further restricting the Ser69-reactive repertoire to only low-avidity T cells. To test this possibility, the CD4 dependency of the cells was evaluated. Antibody to CD4 more readily inhibited the Ser69 response of G2-Tg spleen cells from Hbb a/~ mice than that from Hbb cs mice (Fig. 3 D) , indicating that Hbb d/s ceils were more dependent on CD4 coreceptor for activation. This result suggested that the Ser69-reactive cells that emerged in Hbb a/~ G2-Tg mice did recognize Ser69 with lower avidity. The Ser69-specific ceils that matured were otherwise similar to ceils from Hbb cs mice (Fig.  2 A) , in terms of TCR-ol usage and precursor frequency (data not shown) and in their recognition of Hbd(64-76) as a TCR antagonist (Figs. 2 B and 3 B) . Overall, these results indicated that the endogenous APL selectively removed the high-avidity component of the T cell response to Ser69, but allowed the remaining low-avidity Ser69-reactive cells to develop normally.
Could the peripheral T cell response to Ser69 be affected by antagonism by the endogenous Hbb a ligand on APC?
We have yet to observe any antagonism by endogenous Hbb d complexes of Set69 responses of purified T cells, either from Hbb s/~ or Hbb a/s G2-Tg mice (data not shown). The number of complexes may be a factor, since TCK antagonism is observable under carefully titrated conditions of suboptimal agonist concentrations and antagonist excess (19) . Also, differences between the endogenous ligand and synthetic Hbd(64-76) peptide in either length, register, or conformation within the MHC binding groove could translate into differences in antagonist ability. Jameson et al. (24) have recently shown that mature T cells limit their response to the positive selecting ligand by decreasing the expression of CD8 molecules. Thus, in the Hbb d/s mice, perhaps surface levels of CD4 are decreased as part of the regulation in preventing the endogenous Hb d (64-76) from antagonizing the Ser69 response. The CD4 level may not need drastic downregulation to see an effect, given that expression of TCR and other coreceptors also may determine whether antagonism occurs. We would argue that, in the periphery, most endogenous peptides can act as antagonists only under unique circumstances such as increased expression of the endogenous peptide or the upregulation of important molecules for T cell activation.
The multiple interactions between Hbd(64-76) and different TCR in this system demonstrate that the capacity to finely discriminate between very similar ligands can govern the fate of a T cell. We propose the following model, depicted in Fig. 4 , to explain our data. In the thymus, for each TCK, a corresponding set of functionally similar "lookalike" ligands defines a narrow avidity window for positive and negative selection (25, 26) . Of note, the Hbb d/s thymus differs from the Hbb s/~ thymus because the added endogenous Hbb a determinant changes the avidity window for selection. In the Hbb ~/~ thymus, the two specificity types of Ser69-reactive cells (Fig. 2) are positively selected on their respective sets of ligands, and proceed to mature. TCR affinity, TCR and coreceptor levels, and determinant density all contribute to avidity and influence thymic selection (21, (27) (28) (29) (30) . Thus, both the Ser69/Hbd(64-76) dual-reactive cells and higher avidity Ser69 only-reactive ceils engage the endogenous Hba(64-76) ligand enough that they are negatively selected. Other Ser69-reactive ceils do not interact strongly with endogenous Hbb a and are still positively selected because their avidity window has not changed.
After exiting into the periphery, mature T cells appear to have higher thresholds of activation than thymocytes (31) . Thus, ligands that are weak agonists for peripheral T cells are very effective at inducing thymic deletion (31) . Similarly, since Hba(64-76) interacted with peripheral T cells as a TCtL antagonist in Hbb a/s G2-Tg mice (Fig. 3 B) , these cells probably were more sensitive to the endogenous Hbb d ligand during thymic development. However, this interaction was too weak (in affinity or avidity) or nonefficacious to induce thymocyte deletion (26) . In fetal thymic organ culture studies, it has been demonstrated that lower avidity TCtL interactions allow positive selection, and higher avidity ones result in negative selection (20, 21) . In the G2-Tg mice, the endogenous Hbb d ligand may act as a positively selecting peptide lookalike for Ser69-specific cells. Other endogenous peptide lookalikes must serve to positively select as well, since Ser69-specific cells emerge in Hbbs/s-transgenic mice, which lack Hbb a ligand. Such endogenous ligands would probably function as TCR antagonists; however, we contend that TCR antagonism is not directly equated with the ability to positively select. TCR antagonist activity is principally an in vitro property displayed by a class of ligands. In the continuum of interactions between a TCR and different APL, positive selection and antagonist peptides represent separate but overlapping portions of the spectrum (1).
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